Filing Details

*	The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

* Based on the 52,351,768 shares of Class A Common Stock, $0.0001 par value per share (“Class A Common Stock”), of the Issuer outstanding as of November 1, 2021, as reported in the Issuer’s Quarterly Report on Form 10-Q, filed with the SEC on November 12, 2021, plus the 8,793,479 shares of Class A Common Stock upon the exercise or conversion of the Derivatives (as defined below) and the Public Warrants (as defined below) beneficially owned.

 

* Based on the 52,351,768 shares of Class A Common Stock outstanding as of November 1, 2021, as reported in the Issuer’s Quarterly Report on Form 10-Q, filed with the SEC on November 12, 2021, plus the 8,793,479 shares of Class A Common Stock upon the exercise or conversion of the Derivatives and the Public Warrants beneficially owned.

 

 

* Based on the 52,351,768 shares of Class A Common Stock outstanding as of November 1, 2021, as reported in the Issuer’s Quarterly Report on Form 10-Q, filed with the SEC on November 12, 2021, plus the 8,793,479 shares of Class A Common Stock upon the exercise or conversion of the Derivatives and the Public Warrants beneficially owned.

.

 

* Based on the 52,351,768 shares of Class A Common Stock outstanding as of November 1, 2021, as reported in the Issuer’s Quarterly Report on Form 10-Q, filed with the SEC on November 12, 2021, plus the 8,793,479 shares of Class A Common Stock upon the exercise or conversion of the Derivatives and the Public Warrants beneficially owned.

 

* Based on the 52,351,768 shares of Class A Common Stock outstanding as of November 1, 2021, as reported in the Issuer’s Quarterly Report on Form 10-Q, filed with the SEC on November 12, 2021, plus the 8,679,194 shares of Class A Common Stock issuable upon the exercise or conversion of the Derivatives beneficially owned. 

 

 

This Amendment No. 1 to Schedule 13D amends and supplements the Schedule 13D filed by (i) Angelo, Gordon & Co., L.P., a Delaware limited partnership (“Angelo Gordon”), (ii) AG GP LLC (formerly AG Partners, LLC), a Delaware limited liability company (“AG GP”), (iii) JAMG LLC a Delaware limited liability company (“JAMG”), (iv) Josh Baumgarten, (v) Adam Schwartz and AG Energy Funding, LLC, a Delaware limited liability company (“(“AG Energy Funding”) with the Securities and Exchange Commission (the “SEC”) on September 17, 2021 (the “Schedule 13D”).

This Amendment No. 1 amends and supplements the Schedule 13D as specifically set forth herein.

All capitalized terms contained herein but not otherwise defined shall have the meanings ascribed to such terms in the Schedule 13D. Information given in response to each item shall be deemed incorporated by reference in all other items, as applicable.

Item 5(a) – (b) is amended and restated to read as follows:

(a) - (b) Items 7 through 11 and 13 of each of the cover pages of this Schedule 13D are incorporated herein by reference.  Such information is based on the sum of (i) 52,351,768 shares of Class A Common Stock outstanding as of November 1, 2021, as reported in the Issuer’s Quarterly Report on Form 10-Q, filed with the SEC on November 12, 2021, plus (ii) the 8,679,194 shares of Class A Common Stock issuable upon the exercise or conversion of the Derivatives held by AG Energy Funding beneficially owned by the Reporting Persons and, in the case of Angelo Gordon, AG GP and Messrs. Baumgarten and Schwartz, the 114,285 shares of Class A Common Stock underlying the Public Warrants held by other investment funds managed by Angelo Gordon (AG Energy Funding and such investment funds, the “Accounts”).

Angelo Gordon, in its capacity as manager of AG Funding, has sole power to vote and dispose of 8,793,479 shares of Class A Common Stock underlying the Derivatives held by AG Energy Funding and the Class A Common Stock underlying the Public Warrants held by other Accounts. As the general partner of Angelo Gordon, AG GP may be deemed to have the sole power to vote and dispose of 8,793,479 shares of Class A Common Stock underlying the Derivatives held by AG Energy Funding and the Class A Common Stock underlying the Public Warrants held by other Accounts. As the co-managing member of AG GP and the co-chief executive officer of Angelo Gordon, Mr. Baumgarten may be deemed to have shared power to vote and dispose of 8,793,479 shares of Class A Common Stock underlying the Derivatives held by AG Energy Funding and the Class A Common Stock underlying the Public Warrants held by other Accounts. As the co-managing member of AG GP and the co-chief executive officer of Angelo Gordon, Mr. Schwartz may be deemed to have shared power to vote and dispose of 8,793,479 shares of Class A Common Stock underlying the Derivatives held by AG Energy Funding and the Class A Common Stock underlying the Public Warrants held by other Accounts.  AG Energy Funding has the sole power to vote 8,679,194 shares of Class A Common Stock underlying the Derivatives it holds and the shared power to dispose of 8,679,194 shares of Class A Common Stock underlying the Derivatives it holds.  For purposes hereof, the “Derivatives” consists of Series A Redeemable Convertible Preferred Stock (the “Series A Preferred Shares”) currently convertible into 305,700 shares of Class A Common Stock, warrants exercisable into 711,112 shares of Class A Common Stock, as further previously described in Item 6 of the Schedule 13D (the “Warrants”), and the Notes.  The Public Warrants are currently exercisable into 114,285 shares of Class A Common Stock.  All shares of Class A Common Stock reported reflect the effect of the reverse stock split on September 30, 2021.

Item 6 is amended by adding the following:

Warrant Agreement

Certain Accounts currently hold an aggregate of 800,000 warrants that were originally issued in connection with the Issuer’s IPO (the “Public Warrants”).  The Public Warrants were originally exercisable for one half of one share of Class A Common Stock and were originally exercisable at an exercise price per whole share of $11.50.  The Public Warrants became exercisable 30 days after the Issuer’s initial business combination, which occurred on November 9, 2018, and will expire at 5:00 p.m., New York City time, five years after the completion of the Issuer’s initial business combination or earlier upon redemption or liquidation. Following the Issuer’s reverse split, the 800,000 warrants are convertible into an aggregate of 114,285 shares of Class A Common Stock at an exercise price per whole share of $40.25.

The foregoing description of the Warrant Agreement relating to the Public Warrants does not purport to be complete and is qualified in its entirety by reference to the complete text of such agreements, which are filed herewith as Exhibit 99.13, which is incorporated herein by reference.

 

 

After reasonable inquiry and to the best of my knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.

Dated: November 17, 2021